1 / 11

140 130 120 110 100

Effect of SGLT-2 inhibitors is different from that of carbohydrate restriction. 140 130 120 110 100. 90 80 70 60 50. 58M, diet:1722kcal/day. Although restriction of carbohydarate reduces post-prandial BG,

Download Presentation

140 130 120 110 100

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Effect of SGLT-2 inhibitors is different from that of carbohydrate restriction 140 130 120 110 100 90 80 70 60 50 58M, diet:1722kcal/day Although restriction of carbohydarate reduces post-prandial BG, SGLT-2 inhibitors can protect pancreatic beta cells by reducing insulin requirement during fasting state.

  2. Beer Beer 330ml (alcohol 6%) caused hypoglycemia Report of adverse event

  3. Cost 205.5 308.3 205.5 411.0 308.3 205.5 yen per day

  4. Tofogliflozinhas the shorter duration of life.

  5. Homeostasis model analysis (HOMA) First description in1979 Turneret al. Turner R, Holman RR, Matthews D, Hockaday TR, Peto J : Insulin deficiency and insulin resistance interaction in diabetes : estimation of relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. (Metabolism 28:1086-1096, 1979.) HOMA INDEX( )=rl=rp Insulin resistance During basal steady state: ( (fPG,fIRI, rp) HGP & Splanchnic 0= PG,fIRI,rl) - Brain (fPG) - Muscle f This is converted to the below formula. The unit of PG is mmol/min. fIRI fIRI 0.4 1.2 1 1 0.4 1.2 1 1 0= × log 0= 3-1.86 -1.5 × log(fPG) - - × × × log 3-1.86 -1.5 × log(fPG) - - × × rl 0.1 14 rl 0.1 0.4 6 14 0.4 6 1+ 1+ 1+ 1+ 1+ 1+ fPG fPG fIRI fPG fIRI fPG +2 +2 rp rp Where fIRI : fasting insulin conc. [mU/L], fPG : fasting PG [mmol/L] rl : liver insulin resistance, rp : peripheral (or muscle) insulin resistance Assuming that rl=rp(=R), the above formula can be solved for R after substituting fPG and fIRI for actual measured values. NOTE: the function above is in steady state.

  6. Then, 0.4 1 1 8 1.2 - 0= log - × × 3-1.86 -1.5 × log(6) × 0.1 6 14 R 0.4 1+ 1+ 1+ 6 8 6 +2 Thus, R R=2.1(when fIRI=8 mU/ml, fPG=108mg/dl(=6mmol/L)) It was possible to solve this equation by a large frame computer in 1979. Now it is easy to solve this equation by an EXCEL file. Note: this calculation was estimated from the figures found in the original Metabolism paper published in 1979. It may possible that Dr. Turner used a different formuola. Calculation of HOMA-IR (example) fIRI fIRI 0.4 1.2 1 1 0.4 1.2 1 1 0= × log 0= 3-1.86 -1.5 × log(fPG) - - × × × log 3-1.86 -1.5 × log(fPG) - - × × rl 0.1 14 rl 0.1 0.4 6 14 0.4 6 1+ 1+ 1+ 1+ 1+ 1+ fPG fPG fIRI fPG fIRI fPG rl=rp(=R),fIRI=8 [mU/ml] , fPG=6 [mmol/L] +2 +2 rp rp M. Matsuda: index of insulin secretion and insulin resistance, Internal Medicine [Japanese] 105:39-44, 2010.

  7. Induction of Simplified HOMA formula Reduced formula (1985 by Matthews D et al.) HOMA-IR= HOMA-b%= Diabetologia 28:412-419, 1985

  8. Personal communication Subject: Re: HOMA-IR under use of SGLT-2 inhibitors Hi, HOMA doesn't give the correct answer when used with SGLT2 inhibitors since the effect of insulin appears greater as more glucose is cleared... So you need to use iHOMA, and change the renal threshold appropriately as described in our Diabetes Care paper: Hill NR, Levy JC, Matthews DR. Expansion of the homeostasis model assessment of beta-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. Diabetes Care. 2013; 36:2324-30. Best wishes David Prof. David R. Matthews Professor of Diabetes Medicine, University of Oxford Emeritus Chairman, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM). Medical tutor, Harris Manchester College, Oxford

  9. iHOMA2 http://www.ihoma.co.uk/ Diabetes Care. 2013; 36:2324-30.

More Related